(VIANEWS) – The NASDAQ opens in less than hour and TherapeuticsMD‘s pre-market value is already 6.39% up.
TherapeuticsMD’s last close was $3.60, 64.64% below its 52-week high of $10.18.
The last session, NASDAQ ended with TherapeuticsMD (TXMD) dropping 1.1% to $3.60. NASDAQ jumped 0.09% to $13,761.53, following the last session’s upward trend on what was a somewhat positive trend exchanging session.
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Earnings Per Share
As for profitability, TherapeuticsMD has a trailing twelve months EPS of $3.37.
TherapeuticsMD has a trailing twelve months price to earnings ratio of 1.07. Meaning, the purchaser of the share is investing $1.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1134.2%.
TherapeuticsMD’s worth is below its 50-day moving average of $4.00 and way below its 200-day moving average of $4.53.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 98.4% and a drop 100.2% for the next.
TherapeuticsMD’s sales growth is negative 97.6% for the current quarter and negative 47.9% for the next.
Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $3.60 at 09:34 EST, way under its 52-week high of $10.18 and way above its 52-week low of $3.25.
More news about TherapeuticsMD (TXMD).